Ortenau Klinikum

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Gastric and oesophageal cancer1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 trial
• Medical Center - University Of Freiburg1 trial

Running trials

• Active, not recruiting

  Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy - DECIDER-2 trial

  2023-507461-26-00· Phase 3· Medical Center - University Of Freiburg· Source

Closed trials

• Completed

  Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

  NCT03081143· Phase 2/3· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Source